Delcath Systems Inc. | Key People and Executives
Jennifer K. Simpson
President, Chief Executive Officer & Director
Simon C. Pedder
Independent Director
Marco Taglietti
Independent Director
William Dodge Rueckert
Independent Director
Jennifer K. Simpson
President, Chief Executive Officer & Director
John Purpura
Executive Vice President-Global Operations
Barbra C. Keck
Secretary, Chief Financial & Accounting Officer
Simon C. Pedder
Independent Director
Marco Taglietti
Independent Director
William Dodge Rueckert
Independent Director
| Address |
1633 Broadway
New York New York 10019
United States
|
|
Employees
|
- |
| Website |
http://www.delcath.com |
| Updated |
07/08/2019 |
| Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY. |
